XML 28 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
DEBT
6 Months Ended
Jun. 30, 2011
Debt [Abstract]  
Debt Disclosure [Text Block]
DEBT
 
 
Dollars in Thousands
 
June 30,

2011
 
December 31,

2010
PGxHealth note payable (1)
$
8,640


 
$
8,640


PGxHealth note payable (2)
494


 
989


 
$
9,134


 
$
9,629


(1)
The First Note is a three year senior secured promissory note to PGxHealth, LLC entered into on December 29, 2010 in conjunction with our acquisition of the FAMILION family of genetic tests from PGxHealth. Interest is payable at 10% per year with quarterly interest payments through March 29, 2012. Thereafter, quarterly installments will include both principal and interest through December 30, 2013.
 
(2)
The Second Note is a one year senior secured promissory note to PGxHealth, LLC entered into on December 31, 2010 for facility improvements made to the CLIA certified laboratory in New Haven, Connecticut. Interest is payable at 6.5% per year with the principal and interest payable in twelve monthly installments with the final payment due on December 31, 2011.
The entire unpaid balance of the Notes will become immediately due and payable if: (i) we fail to make timely payments under the Notes; (ii) we make an assignment for the benefit of creditors; (iii) we file for bankruptcy; or (iv) upon any event of default under the Security Agreement. Additionally, under the terms of the First Note, if we consummate an equity financing that involves the receipt by us of net proceeds of not less than $6,000,000, then we shall, upon the consummation of such equity financing, pay to PGxHealth the lesser of: (i) 25% of the gross proceeds received from such financing; and (ii) the then-outstanding balance under the First Note. Under the terms of the Second Note, in the event of a sale of all or substantially all of the assets of the Company, we shall pay PGxHealth the lesser of: (i) 100% of the proceeds, less certain fees, received pursuant to such sale; and (ii) the then-outstanding balance under the Second Note.
The Notes are secured by the assets of Transgenomic.
The aggregate minimum principal maturities of the debt for each of the three fiscal years following June 30, 2011 are as follows:
 
2011
$
1,728


2012
3,703


2013
3,703


 
$
9,134